Compare · ACCD vs FTAC
ACCD vs FTAC
Side-by-side comparison of Accolade Inc. (ACCD) and FinTech Acquisition Corp. III (FTAC): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while FTAC operates in Finance - the two are in different parts of the market.
- ACCD carries a market cap of $1.18B.
- ACCD has more recent analyst coverage (25 ratings vs 0 for FTAC).
- Company
- Accolade Inc.
- FinTech Acquisition Corp. III
- Price
- $7.03+0.00%
- -
- Market cap
- $1.18B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2019
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest FTAC
- Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Nuvei Corp. (NASDAQ: NVEI / TSX: NVEI)
- SEC Form SC 13G/A filed
- SEC Form SC 13G/A filed
- SEC Form SC 13G/A filed
- SEC Form SC 13G/A filed
- SEC Form SC 13G/A filed
- GTCR Announces Completion of Paya's Public Offering via SPAC Merger
- Paya and FinTech III Announce Filing of Definitive Proxy Statement in Connection with Proposed Transaction